发明名称 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
摘要 A cytotoxic agent comprising one or more modified doxorubicins/daunorubicin linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more modified doxorubicins/daunorubicins covalently bonded to a cell binding agent through a linking group, and (B) a pharmaceutically acceptable carrier. A method for killing selected cell populations comprising contacting target cells or tissue containing target cells with an effective amount of a cytotoxic agent comprising one or more modified doxorubicins/daunorubicins linked to a cell binding agent. Novel sulfur-containing modified doxorubicins/daunorubicins.
申请公布号 NZ518764(A) 申请公布日期 2004.02.27
申请号 NZ20000518764 申请日期 2000.12.19
申请人 IMMUNOGEN, INC 发明人 CHARI, RAVI V J;BLATTLER, WALTER A
分类号 C07H19/04;A61K31/706;A61P31/04;A61P31/12;A61P33/00;A61P35/00;A61P37/02;A61P43/00;C07H15/252;C07H19/24;(IPC1-7):C07H15/252;A61K31/704 主分类号 C07H19/04
代理机构 代理人
主权项
地址